Ras-responsive genes and tumor metastasis
- PMID: 8420573
Ras-responsive genes and tumor metastasis
Abstract
Transfected ras oncogenes have been shown to induce metastatic properties in some cells. Clarification of the mechanisms by which ras is able to increase the metastatic ability in model systems will improve our understanding of tumor progression to metastasis, even in those cells in which ras activation has not been implicated. Many of the consequences of ras expression also have been detected in cells that have become metastatic in the apparent absence of an altered ras gene, suggesting that there is a set of common changes that can lead to metastasis with multiple signals capable of eliciting these changes. These changes, which have been documented for some ras-transformed cells, include increased expression or activity of various degradative enzymes, including metalloproteinases (type IV collagenases) and cysteine proteinases (cathepsins L and B), as well as decreased expression or activity of their inhibitors (TIMPs and cystatins, respectively). In addition, some metastatic ras-transformed cells have an increased expression of calcyclin, a cytoplasmic calcium-binding protein, and osteopontin, a secreted calcium-binding protein with possible adhesive function. Not all cells, however, respond in the same fashion to a ras oncogene signal. Some cells are resistant to ras-mediated tumor progression to metastasis. Understanding the mechanism by which these cells fail to respond to a specific oncogene signal may provide clues with broader applicability and potential therapeutic relevance. In this review, we summarize some of the studies in which ras has been used as a tool to learn about the molecular requirements for metastasis. We discuss ras-mediated changes in gene expression and how these may contribute to metastatic ability, as well as some possible mechanisms by which ras expression may result in altered expression of other genes. We also consider some cell lines which appear to be resistant to an oncogenic ras signal and possible mechanisms for this nonresponsiveness. These studies are providing insights into the molecular mechanisms of tumor metastasis and the responses of cells to oncogenic signals.
Similar articles
-
Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.Oncogene. 1993 May;8(5):1211-9. Oncogene. 1993. PMID: 8479744
-
Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.Anticancer Res. 1992 Jan-Feb;12(1):43-7. Anticancer Res. 1992. PMID: 1567180
-
Oncogenes and metastatic progression.Invasion Metastasis. 1989;9(6):360-78. Invasion Metastasis. 1989. PMID: 2689384 Review.
-
Oncogene transformation and the metastatic phenotype.Anticancer Res. 1988 Sep-Oct;8(5A):861-71. Anticancer Res. 1988. PMID: 3052258 Review.
-
Tumorigenic and metastatic properties of two ras-oncogene transfected rat fibrosarcoma cell lines defective in c-jun.Oncogene. 1994 Dec;9(12):3655-63. Oncogene. 1994. PMID: 7970724
Cited by
-
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4089-94. doi: 10.1073/pnas.061031898. Epub 2001 Mar 20. Proc Natl Acad Sci U S A. 2001. PMID: 11259649 Free PMC article.
-
Osteopontin: an effector and an effect of tumor metastasis.Curr Mol Med. 2010 Feb;10(1):71-81. doi: 10.2174/156652410791065381. Curr Mol Med. 2010. PMID: 20205680 Free PMC article. Review.
-
A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.Clin Exp Metastasis. 2004;21(2):119-28. doi: 10.1023/b:clin.0000024763.69809.64. Clin Exp Metastasis. 2004. PMID: 15168729
-
Overexpression of human osteopontin increases cell proliferation and migration in human embryo kidney-293 cells.Cell Mol Biol Lett. 2009;14(4):670-8. doi: 10.2478/s11658-009-0027-z. Epub 2009 Jun 27. Cell Mol Biol Lett. 2009. PMID: 19562270 Free PMC article.
-
Targeting Cathepsin B for Cancer Therapies.Horiz Cancer Res. 2015 2nd Quarter;56:23-40. Horiz Cancer Res. 2015. PMID: 26623174 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous